Prestige Consumer Healthcare (PBH) Change in Receivables (2010 - 2025)

Prestige Consumer Healthcare's (PBH) quarterly Change in Receivables came in at -$495000.0 in Q4 2025, down 107.84% year-on-year from $6.3 million in Q4 2024, and down 101.65% quarter-over-quarter from $29.9 million in Q3 2025.

Prestige Consumer Healthcare (PBH) Change in Receivables (2010 - 2025) Analysis & Trends

Prestige Consumer Healthcare's Change in Receivables history runs 16 years deep, the most recent figure standing at -$495000.0 for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 107.84% year-over-year to -$495000.0 in Q4 2025; TTM through Dec 2025 was $27.3 million, a 385.15% increase from a year earlier, with the FY2025 full-year figure at $16.3 million, up 158.26% from the prior year.
  • Change in Receivables retreated to -$495000.0 in Q4 2025 per PBH's latest filing, from $29.9 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $29.9 million in Q3 2025 and bottomed at -$27.3 million in Q2 2025.
  • The 5-year median for Change in Receivables is $2.0 million (2022), against an average of $3.7 million.
  • Across the five-year window, Change in Receivables tumbled 824.98% in 2024 and surged 3726.04% in 2025, its largest moves.
  • Year by year, Change in Receivables stood at -$12.5 million in 2021, then jumped by 170.56% to $8.8 million in 2022, then rose by 29.88% to $11.4 million in 2023, then plunged by 44.74% to $6.3 million in 2024, then slumped by 107.84% to -$495000.0 in 2025.
  • Per Business Quant, the three latest PBH Change in Receivables figures stand at -$495000.0 (Q4 2025), $29.9 million (Q3 2025), and -$27.3 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -78.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 106.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -621.82 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -38.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 126.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 81.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Prestige Consumer Healthcare 2.34 Bn 2.28 Bn 157.37 Mn -495,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -495,000.00
Dec 31, 2025 -495,000.00
Sep 30, 2025 29.92 Mn
Sep 30, 2025 29.92 Mn
Jun 30, 2025 -27.34 Mn
Jun 30, 2025 -27.34 Mn
Mar 31, 2025 25.20 Mn
Mar 31, 2025 25.20 Mn
Dec 31, 2024 6.32 Mn
Dec 31, 2024 6.32 Mn
Sep 30, 2024 -8.82 Mn
Sep 30, 2024 -8.82 Mn
Jun 30, 2024 -6.37 Mn
Jun 30, 2024 -6.37 Mn
Mar 31, 2024 -695,000.00
Mar 31, 2024 -695,000.00
Dec 31, 2023 11.43 Mn
Dec 31, 2023 11.43 Mn
Sep 30, 2023 1.22 Mn
Sep 30, 2023 1.22 Mn